Last updated on February 2011

TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer

Brief description of study

A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Survival Free of Laryngectomy in Patients With Resectable and Locally Advanced Larynx Cancer, After Treatment With TPF Chemotherapy.

Detailed Study Description

This study is being sponsored by a cooperative medical group.

Clinical Study Identifier: NCT00765011

Contact Investigators or Research Sites near you

Start Over

Ricard Mesia, MD

Hospital Duran i Reynals
L'Hospitalet de Llobregat, Spain
  Connect »

Juan J Grau, MD

Hospital Cl nic i Provincial de Barcelona
Barcelona, Spain
  Connect »

Beatriz Cirauqui, MD

Hospital Germans Trias i Pujol
Badalona, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.